300194 福安药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.1165.7325.329-7.5805.177
总资产报酬率 ROA (%)3.6163.9123.532-5.0843.910
投入资产回报率 ROIC (%)4.1234.5374.109-5.9754.547

边际利润分析
销售毛利率 (%)53.36753.36558.36962.84565.397
营业利润率 (%)17.44111.2737.372-24.09110.166
息税前利润/营业总收入 (%)16.94410.8807.726-24.1459.986
净利润/营业总收入 (%)15.0428.8538.292-24.8498.688

收益指标分析
经营活动净收益/利润总额(%)74.66865.22865.775-26.78075.896
价值变动净收益/利润总额(%)17.18426.79532.830-8.86416.521
营业外收支净额/利润总额(%)-1.662-2.8015.7180.1670.146

偿债能力分析
流动比率 (X)1.5901.7791.4971.6181.836
速动比率 (X)1.0201.1870.9381.1281.280
资产负债率 (%)27.94030.57632.86032.2550.237
带息债务/全部投入资本 (%)15.70017.71914.40518.78113.125
股东权益/带息债务 (%)520.226448.666546.979401.453626.447
股东权益/负债合计 (%)257.735226.838204.249202.874289.209
利息保障倍数 (X)-80.219-126.154-83.0581,778.227-51.265

营运能力分析
应收账款周转天数 (天)31.63738.52847.18644.33947.487
存货周转天数 (天)199.252208.099241.324241.343243.785